A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

Author： Malik Imtiaz   Bernal Pedro   Byrd Janet  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.28, Iss.8, 2010-09, pp. : 833-838

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer

By Andersen Maria   Schønnemann Katrine R.   Yilmaz Mette   Jensen Helle A.   Vestermark Lene W.   Pfeiffer Per  

Acta Oncologica, Vol. 49, Iss. 8, 2010-11 ,pp. : 1246-1252

Informa Healthcare

Access to resources Recommend Favorite

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

By Chao Yee   Hsieh Jan-Sing   Yeh Hsien-Tang   Su Yu-Chieh   Wu Cheng-Chung   Chen Jen-Shi   Tai Cheng-Jeng   Bai Li-Yuan   Yeh Kun-Huei   Su Wu-Chou   Li Chung-Pin  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 799-806

Springer Publishing Company

Access to resources Recommend Favorite

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

By Raez Luis   Santos Edgardo   Webb R.   Wade James   Brito Roger   Karr Melissa   Kennah Andra   Childs Barrett  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1103-1110

Springer Publishing Company

Access to resources Recommend Favorite

New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer

By Schønnemann Katrine R.   Yilmaz Mette   Andersen Maria   Pfeiffer Per  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 151-152

Informa Healthcare

Access to resources Recommend Favorite

A phase II study - docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

By Rougier P.   Adenis A.   Ducreux M.   de Forni M.   Bonneterre J.   Dembak M.   Clouet P.   Lebecq A.   Baille P.   Lefresne-Soulas F.   Blanc C.   Armand J.P.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 1016-1025

Elsevier

Access to resources Recommend Favorite